The Recall Desk

FDA (Drugs) recall action 64608

Teva Pharmaceuticals USA, Inc. recalled 2 products on 2013-06-05

The FDA (Drugs) publishes a recall like this one as 2 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 2 pages.

Products
2
Announced
2013-06-05
Critical
0
Units
137,157

Why these products were recalled

Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) detected during impurity testing

Failed Impurity/Degradation Specifications; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) detected during impurity testing

The agency’s own wording, quoted from the enforcement report.

The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.

1–2 of 2

  • ModerateFDA (Drugs)··2013-06-05

    Teva Recalls Seasonale Tablets Due to Impurity Detection

    Teva Pharmaceuticals is recalling Seasonale tablets because testing detected an impurity called N-Butyl-Benzene Sulfonamide.

    Product
    Seasonale(R) (Levonorgestrel/Ethinyl Estradiol Tablets), 0.15 mg/0.03 mg, 3 extended-cycle tablet dispensers, 91 tablets each, Rx only, TEVA Women Health, Inc., Subsidiary of TEVA Pharmaceuticals USA, Inc., Sellersville, PA NDC 51285-058-66
    Category
    Distribution
    0 states
  • ModerateFDA (Drugs)··2013-06-05

    Teva Recalls Camrese Oral Contraceptives Due to Impurity Detection

    Teva Pharmaceuticals is recalling Camrese oral contraceptives because an impurity called N-Butyl-Benzene Sulfonamide was detected during testing.

    Product
    CAMRESE (LEVONORGESTREL / ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL)
    Category
    Distribution
    0 states